Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
17.1%
% of BMED's 115 holdings also in FBT
60.0%
% of FBT's 31 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 4.3% | 3.7% |
 |
ARGENX SE ADR | 3.3% | 3.1% | 3.1% |
|
REPLIGEN CORP | 2.1% | 3.0% | 2.1% |
|
WATERS CORP | 2.0% | 3.3% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.5% | 2.8% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to FBT
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
BIO-TECHNE CORPORATION | 1.8% |
BMED Underweight Relative to FBT
|
INTRA-CELLULAR THERAPIES INC | -4.8% |
|
VERTEX PHARMACEUTICALS INC | -3.9% |
|
BEIGENE LTD. SPONSORED ADR | -3.9% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
ALKERMES PLC | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.7% |
|
HALOZYME THERAPEUTICS INC | -3.6% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
METTLER-TOLEDO INTERNATIONAL | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.2% |